Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Mennetrey C, Le Bras M, Bando-Delaunay A, Al-Mansour L, Haissaguerre M, Batisse-Lignier M, Ouvrard E, Ansquer C, Walter T, de Mestier L, Kelly A, Tlili G, Giraud S, North MO, Odou MF, Goichot B, Cuny T, Loundou A, Romanet P, Imperiale A, Taïeb D. Mennetrey C, et al. Among authors: kelly a. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2056-e2064. doi: 10.1210/clinem/dgab891. J Clin Endocrinol Metab. 2022. PMID: 34940846
Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod).
Leenhardt L, Leboulleux S, Bournaud C, Zerdoud S, Schvartz C, Ciappuccini R, Kelly A, Morel O, Dygai-Cochet I, Rusu D, Chougnet CN, Lion G, Eberlé-Pouzeratte MC, Catargi B, Kabir-Ahmadi M, Le Peillet Feuillet E, Taïeb D. Leenhardt L, et al. Among authors: kelly a. J Clin Endocrinol Metab. 2019 Apr 1;104(4):1020-1028. doi: 10.1210/jc.2018-01589. J Clin Endocrinol Metab. 2019. PMID: 30398518
Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer.
Bouvet C, Barres B, Kwiatkowski F, Batisse-Lignier M, Chafai El Alaoui M, Kauffmann P, Cachin F, Tauveron I, Kelly A, Maqdasy S. Bouvet C, et al. Among authors: kelly a. Front Endocrinol (Lausanne). 2019 Sep 27;10:671. doi: 10.3389/fendo.2019.00671. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31611847 Free PMC article.
Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
Garrigues G, Batisse-Lignier M, Uhrhammer N, Privat M, Ponelle-Chachuat F, Kelly A, Gay-Bellile M, Viala S, Bidet Y, Bignon YJ, Cavaillé M. Garrigues G, et al. Among authors: kelly a. Mol Genet Genomic Med. 2023 May;11(5):e2133. doi: 10.1002/mgg3.2133. Epub 2023 Jan 14. Mol Genet Genomic Med. 2023. PMID: 36639964 Free PMC article. Review.
Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.
Boucher A, Delabie J, Lussey-Lepoutre C, Haissaguerre M, Ouvrard E, Lavinia V, Le Bras M, Batisse-Lignier M, Cuny T, Jacquet-Francillon N, Gaujoux S, Molina O, Imperiale A, Latge A, Ansquer C, Kelly A, Borson-Chazot F, Tlili G, Sebag F, Hamidou Z, Romanet P, Taïeb D. Boucher A, et al. Among authors: kelly a. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1349-1360. doi: 10.1007/s00259-023-06537-1. Epub 2023 Dec 7. Eur J Nucl Med Mol Imaging. 2024. PMID: 38057652
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Cachin F, Miot-Noirault E, Gillet B, Isnardi V, Labeille B, Payoux P, Meyer N, Cammilleri S, Gaudy C, Razzouk-Cadet M, Lacour JP, Granel-Brocard F, Tychyj C, Benbouzid F, Grange JD, Baulieu F, Kelly A, Merlin C, Mestas D, Gachon F, Chezal JM, Degoul F, D'Incan M. Cachin F, et al. Among authors: kelly a. J Nucl Med. 2014 Jan;55(1):15-22. doi: 10.2967/jnumed.113.123554. Epub 2013 Nov 21. J Nucl Med. 2014. PMID: 24263087 Free article. Clinical Trial.
3,618 results